Hanson Wade light-logo dark-logo-new

Bring Safe, Effective & More Precise Therapies to Autoimmune Patients Faster

With a focus on T-cell engagers, cell therapies, b-cell mediated approaches, regulatory T cells (Tregs), and antigen-specific immune tolerance, our mission is to connect the scientific and biopharmaceutical communities to uncover translational opportunities, overcome development challenges and accelerate the approval of more precise therapies that address the patient health burden associated with autoimmunity.

Conference

2nd T-Cell Engager for Autoimmune Disease Summit

October 2026
Diversify Your Engager Pipeline Beyond Oncology
Autoimmune & Immunology
Conference

10th Dermatology Drug Development Summit

November 2026
Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
Autoimmune & Immunology
Conference

4th Cell Therapy for Autoimmune Disease Summit

December 2026
From Promise to Reality: Advancing Cell Therapies in Autoimmunity
Autoimmune & Immunology
Conference

10th Complement-Based Drug Development Summit

December 2026
Maximize Complement Targeting from Cascade Mechanistic Modelling to Phase II Proof-of-Concept
Autoimmune & Immunology
Conference

2nd Immune Resetting: B-Cell Mediated & Beyond

March 2027
Accelerating Curative Therapies for Autoimmune Diseases
Autoimmune & Immunology
Conference

9th Treg-Directed Therapies Summit

March 2027
Expand the Application of Treg Therapies into a Clinical Reality
Autoimmune & Immunology
Conference

10th Antigen-Specific Immune Tolerance Summit

March 2027
Advancing Transformative Therapies to Reset Autoimmune Diseases
Autoimmune & Immunology

View and search all of our conferences.

ConferencesView All Conferences

Testimonials

“The Antigen-Specific Immune Tolerance Summit has a great mixture of examples illustrating clinical development progress and emerging new technologies to induce immune tolerance”

Moderna

“An excellent opportunity to catch up on latest developments and advancements in the ASIT field, with most key players represented”

Toleranzia

“Exciting presentations with emerging clinical data”

Eli Lily & Co

“Good quality of presentations. Participants had a strong commitment to dermatology and the advancement of science in the field”

Michael Herbig, Chief Executive Officer
RaDes GmbH

What to Expect at Hanson Wade Conferences?

CONTACT US

Get in touch

We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.

Standard Form - Autoimmune & Immunology

"*" indicates required fields

Fill out the form below with your question and one of our team will get back to you.